Track MLYS and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
MLYS - Mineralys Therapeutics, Inc. Common Stock (MLYS) has a earnings per share of -$0.47, up 40.5% over the past year.
Latest EPS (Actual)
-$0.47
Beat Rate
62.5%
Most Recent
Miss
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| May 2026 | -$0.44 | -$0.47 | Miss | -6.82% |
| Mar 2026 | -$0.94 | -$0.40 | Beat | +57.45% |
| Nov 2025 | -$0.61 | -$0.52 | Beat | +14.75% |
| Aug 2025 | -$0.74 | -$0.66 | Beat | +10.81% |
| May 2025 | -$0.98 | -$0.79 | Beat | +19.39% |
| Feb 2025 | -$1.08 | -$0.98 | Beat | +9.26% |
| Nov 2024 | -$0.83 | -$1.13 | Miss | -36.14% |
| Aug 2024 | -$0.70 | -$0.83 | Miss | -18.57% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.